Wall Street Zen cut shares of Phreesia (NYSE:PHR – Free Report) from a buy rating to a hold rating in a research report sent to investors on Saturday morning,Wall Street Zen reports.
Several other brokerages have also issued reports on PHR. Barclays lifted their price target on shares of Phreesia from $10.00 to $11.00 and gave the company an “equal weight” rating in a report on Monday, October 12th. Robert W. Baird upped their price objective on shares of Phreesia from $10.00 to $11.00 and gave the stock a “neutral” rating in a research report on Friday, September 4th. Raymond James Financial cut shares of Phreesia from an “outperform” rating to a “market perform” rating in a research note on Tuesday, September 8th. Citigroup reiterated a “market perform” rating on shares of Phreesia in a report on Tuesday. Finally, Wells Fargo & Company increased their price target on Phreesia from $9.00 to $10.00 and gave the company an “equal weight” rating in a research note on Thursday, September 3rd. Eight research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $14.07.
Read Our Latest Report on Phreesia
Phreesia Price Performance
Phreesia stock opened at $12.67 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.76 and a current ratio of 1.76. Phreesia has a 52 week low of $7.77 and a 52 week high of $23.99. The stock has a market capitalization of $786.18 million, a P/E ratio of 74.51 and a beta of 0.84. The stock has a fifty day moving average of $10.96 and a 200-day moving average of $10.29.
Phreesia (NYSE:PHR – Get Free Report) last released its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.06). Phreesia had a net margin of 2.06% and a return on equity of 5.22%. The business had revenue of $129.46 million during the quarter, compared to analyst estimates of $129.06 million. During the same period last year, the business earned $0.01 earnings per share. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts expect that Phreesia will post 0.33 earnings per share for the current fiscal year.
Insider Activity
In other Phreesia news, General Counsel Allison C. Hoffman sold 6,662 shares of the stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $10.08, for a total transaction of $67,152.96. Following the completion of the sale, the general counsel owned 266,574 shares of the company’s stock, valued at approximately $2,687,065.92. This represents a 2.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 5.20% of the stock is owned by company insiders.
Institutional Investors Weigh In On Phreesia
A number of institutional investors have recently modified their holdings of the company. Rockefeller Capital Management L.P. raised its position in shares of Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after acquiring an additional 2,149 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in Phreesia by 1,119.8% during the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after purchasing an additional 3,001 shares during the period. New York State Teachers Retirement System bought a new stake in Phreesia in the first quarter worth approximately $44,000. Allworth Financial LP bought a new stake in Phreesia in the second quarter worth approximately $58,000. Finally, Essential Partners LLC increased its holdings in Phreesia by 2,016.6% in the first quarter. Essential Partners LLC now owns 9,313 shares of the company’s stock worth $78,000 after purchasing an additional 8,873 shares in the last quarter. 92.10% of the stock is owned by institutional investors.
About Phreesia
Phreesia, Inc is a healthcare technology company that provides a platform for managing administrative and financial interactions between healthcare organizations and their patients. Its software is designed to help medical practices and other care providers streamline registration, intake, payments, communications and related workflows.
The Phreesia platform includes digital patient check-in tools that allow patients to complete forms, update demographic and insurance information, make payments and review relevant educational or administrative content.
Featured Articles
- Five stocks we like better than Phreesia
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.
